XML 26 R16.htm IDEA: XBRL DOCUMENT v3.19.1
Asset Impairment, Restructuring, and Other Special Charges
3 Months Ended
Mar. 31, 2019
Restructuring and Related Activities [Abstract]  
Asset Impairment, Restructuring, and Other Special Charges
Asset Impairment, Restructuring, and Other Special Charges
The components of the charges included in asset impairment, restructuring, and other special charges in our consolidated condensed statements of operations are described below.
 
Three Months Ended
March 31,
 
2019
 
2018
Severance
$
(3.6
)
 
$
7.3

Asset impairment and other special charges
427.5

 
49.5

Total asset impairment, restructuring, and other special charges
$
423.9

 
$
56.8


Asset impairment and other special charges recognized during the three months ended March 31, 2019 consisted of $400.7 million related to the acquisition of Loxo, substantially all of which is associated with the accelerated vesting of Loxo employee equity awards.
Asset impairment, restructuring, and other special charges recognized during the three months ended March 31, 2018 were primarily associated with asset impairment, exit costs, and severance costs related to the decision to end Posilac® (rbST) production at the Augusta, Georgia manufacturing site.